FLGT Q1 2018 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$447M

Q1 2018 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$5M-12.3% YoY

Gross Profit

$2M40.4% margin

Operating Income

-$2M-47.2% margin

Net Income

-$2M-41.0% margin

EPS (Diluted)

$-0.11

QoQ Revenue Growth

+8.7%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$2M

Stock-Based Comp.

$545,000

Balance Sheet

Total Assets

$56M

Total Liabilities

$2M

Stockholders' Equity

$53M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$5M	-12.3%
Gross Profit	$2M	$3M	-45.4%
Operating Income	-$2M	$219,000	-1101.8%
Net Income	-$2M	$232,000	-923.3%

Revenue Segments

Genetic Testing Services

$5M100%

Geographic Segments

UNITED STATES

$3M54%

Other Countries

$1M24%

CANADA

$970,00021%

CHINA

$24,0001%